Teaching Doctors in Training to Reason With Artificial Intelligence
Condition(s) studied
Investigational drug(s) / intervention(s)
Workshop-First: Participants will attend a workshop during their didactic time that will review various aspects of large language models including fundamentals and best practices of interacting and interpreting their outputs.
Study summary
The purpose of the TEACH-AI study is to assess whether a brief, structured workshop on artificial intelligence can improve the performance of medicine doctors in training (i.e. residents) in their diagnostic and management reasoning.
In this multi-site randomized controlled trial, internal medicine and family medicine residents are assigned either to receive an in-person workshop on safe, effective LLM use before a standardized AI-assisted assessment, or to complete the same assessment before receiving the workshop. Residents will review clinical cases that are fully synthetic, no protected health information is used, using a password protected LLM interface.
Eligibility
Primary outcome measure(s)
- Total Score on Expert-Development Rubrics — Within 24 hours of assessment completion.
The primary outcome will be the number of correct responses for all cases using select questions from expert-developed scoring rubrics. The rubrics were developed using a Delphi consensus process by expert physicians as established by Goh et al (Nature Medicine, 2025; DOI: 10.1038/s41591-024-03456-y). The primary outcome will be analyzed at the case level, comparing performance between the randomized study groups, with a higher number of correct responses indicating a better outcome.
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| Stanford University | Palo Alto | California | |
| AdventHealth | Orlando | Florida | |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | |
| Cambridge Health Alliance | Cambridge | Massachusetts |
More Beth Israel Deaconess Medical Center trials in Israel
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07813754 on ClinicalTrials.gov ↗ ← All trials in Israel